Success Story: Our Firm Helped An Ethiopian Postdoctoral Scholar Achieve NIW Approval with Premium Processing
Client’s Testimonial:
“Thank you so much for your unwavering support. You are a truly dedicated professional.”
On March 13th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Scholar in the Field of Biomedical Life Sciences (Approval Notice).
General Field: Biomedical Life Sciences
Position at the Time of Case Filing: Postdoctoral Scholar
Country of Origin: Ethiopia
State of Residence at the Time of Filing: Tennessee
Approval Notice Date: March 13th, 2025
Processing Time: 2 months, 4 days (Premium Processing Requested)
Case Summary:
We are pleased to share the success of an EB-2 National Interest Waiver (NIW) petition filed on behalf of a distinguished researcher, whose I-140 was approved just a little over two months after filing under premium processing.
The client holds a Ph.D. in health technology and informatics and is actively engaged in groundbreaking research within the field of biomedical life sciences. His work focuses on investigating host-pathogen interactions and the underlying mechanisms of protective immune responses. His proposed endeavor centers on advancing innovative immunization strategies and translational studies aimed at developing effective vaccines and therapeutics targeting infectious pathogens. These contributions directly support global efforts to combat infectious diseases and strengthen public health systems.
At the time of filing, the client was conducting research in the United States that aligned with his proposed endeavor. He had authored 18 peer-reviewed journal articles, 5 of which he first-authored, and his research had been cited 25515 times - an extraordinary figure that places him among the most influential researchers in clinical medicine globally. He had also conducted at least 6 peer reviews for respected journals in his field, further underscoring his expertise and recognition among peers.
In demonstrating the client’s eligibility, our team emphasized the significant merit and national importance of his work, as well as his well-documented record of success. The petition highlighted how his research has been widely adopted and cited by other scientists, and how his findings have influenced vaccine development, antimicrobial resistance studies, and global burden of disease assessments.
With a strong petition that clearly established his qualifications and the substantial impact of his research, the client’s case was approved without delay under the premium processing timeline. His story adds to the growing list of successful outcomes supported by the NAILG team.

